EASD 2025
15 - 19 September 2025
Revolutionising Cardiometabolic Health: Innovating, Transforming and Progressing Care
Meeting description
Meeting recording (Part 3)
Meeting recording (Part 4)
Meeting recording (Part 5)
Meeting recording (Part 1)
Meeting recording (Part 2)
Monday, 15 September 2025
09:00 - 10:40
(CEST)
Part 1: Exploring the background of person-centred care across the spectrum of related cardiometabolic diseases
09:00 - 09:15
(CEST)
The Prologue: welcome and introductions
Alice Cheng, Mikael Rydén
09:15 - 09:35
(CEST)
Chapter 1: Person-centred care - the evolving landscape and new horizons in obesity management
Carel le Roux
09:35 - 09:55
(CEST)
Chapter 2: Person-centred care - the need for treatment of cardiometabolic diseases
John Buse
09:55 - 10:10
(CEST)
Chapter 3: Focus on PAD - synergistic strategies across ASCVD
Subodh Verma
10:10 - 10:25
(CEST)
Chapter 4: Person-centred care - heart failure for people with cardiometabolic diseases
Michele Senni
10:25 - 10:40
(CEST)
Chapter 5: Summarising the evidence for person-centred care across cardiometabolic diseases
Alice Cheng, Mikael Rydén, Carel le Roux, John Buse, Subodh Verma, Michele Senni
10:55 - 12:05
(CEST)
Part 2: Focusing in on an expanding spectrum of cardiometabolic diseases and patient phenotypes
10:55 - 11:00
(CEST)
Checking the contents page: welcome back
Alice Cheng, Mikael Rydén
11:00 - 11:15
(CEST)
Chapter 6: Focus on kidneys - synergistic strategies across cardiometabolic diseases
Christoph Wanner
11:15 - 11:35
(CEST)
Chapter 7: Focus on MASH - integrating emerging data into clinical pathways
Laurent Castera
11:35 - 11:50
(CEST)
Chapter 8: Focus on childhood - charting new paths in obesity management
Antje Körner
11:50 - 12:05
(CEST)
Chapter 9: Summarising the focus and translating it into clinical practice
Alice Cheng, Mikael Rydén, Christoph Wanner, Laurent Castera, Antje Körner
12:45 - 14:10
(CEST)
Part 3: Semaglutide and the path to holistic cardiometabolic disease care
12:45 - 12:50
(CEST)
Checking the contents page: welcome back
Alice Cheng, Mikael Rydén
12:50 - 13:15
(CEST)
Chapter 10: The prequel to semaglutide and the evidence that started the journey
Anna Secher
13:15 - 13:40
(CEST)
Chapter 11: The science of the cardiometabolic care - clinical evidence and perspectives
Arya M. Sharma
13:40 - 13:55
(CEST)
Chapter 12: The voice of the patient - hearing their call to action for personalised care
13:55 - 14:10
(CEST)
Chapter 13: Summarising the journey and exploring the
co-authors’ views
Alice Cheng, Mikael Rydén, Anna Secher, Arya M. Sharma
14:25 - 15:50
(CEST)
Part 4: The future chapters - advancing the management of cardiometabolic diseases
14:25 - 14:30
(CEST)
Checking the contents page: welcome back
Alice Cheng, Mikael Rydén
14:30 - 14:45
(CEST)
Chapter 14: Advancements in nutrient-stimulated hormone therapies: the evolution of amylin
Matthias Blüher
14:45 - 15:00
(CEST)
Chapter 15: Advancements to clinical excellence in obesity through the potential of complementary biologies
W. Timothy Garvey
15:00 - 15:15
(CEST)
Chapter 16: Advancements across the metabolic disease continuum - expanding the evidence
Melanie Davies
15:15 - 15:30
(CEST)
Chapter 17: Advancements in the treatment toolbox - integrating amycretin
Ania Jastreboff
15:30 - 15:50
(CEST)
Chapter 18: Summarising the advancements and looking to a future of clinical excellence
Alice Cheng
16:05 - 17:00
(CEST)
Part 5: Innovating our heritage - once-weekly basal insulin therapy
16:05 - 16:10
(CEST)
Checking the contents page: welcome back
Alice Cheng, Mikael Rydén
16:10 - 16:30
(CEST)
Chapter 19: Innovation in basal insulins - individualised treatment in focus
Athena Philis-Tsimikas, Harald Sourij
16:30 - 16:45
(CEST)
Chapter 20: Innovation in combination insulin therapy - benefits beyond glycaemic control
Linong Ji
16:45 - 16:55
(CEST)
Chapter 21: Summarising the innovation for people in need of insulin
Alice Cheng, Mikael Rydén, Athena Philis-Tsimikas, Harald Sourij, Linong Ji
16:55 - 17:00
(CEST)
The Epilogue: summary and close
Alice Cheng, Mikael Rydén
Keywords